M-M-R II|MMR|03        |Merck and Co., Inc.|MSD       |Active|Active|2020/06/02|
ProQuad|MMRV|94        |Merck and Co., Inc.|MSD       |Active|Active|2020/06/02|
GARDASIL|HPV, quadrivalent|62        |Merck and Co., Inc.|MSD       |Active|Inactive|2010/05/28|
Gardasil 9|HPV9|165       |Merck and Co., Inc.|MSD       |Active|Active|2014/12/11|
COMIRNATY|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose|208       |Pfizer, Inc|PFR       |Active|Active|2023/09/06|
COMIRNATY|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose|217       |Pfizer, Inc|PFR       |Active|Active|2023/09/06|
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose|208       |Pfizer, Inc|PFR       |Active|Inactive|2025/09/09|
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)|COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose|217       |Pfizer, Inc|PFR       |Active|Inactive|2025/09/09|
PREVNAR 13|Pneumococcal conjugate PCV 13|133       |Pfizer, Inc|PFR       |Active|Active|2010/05/28|
PREVNAR 13|Pneumococcal conjugate PCV 13|133       |Wyeth|WAL       |Active|Inactive|2010/05/28|
Fluzone trivalent, preservative free|Influenza, split virus, trivalent, PF|140       |Sanofi Pasteur|PMC       |Active|Active|2024/05/17|
Fluzone trivalent, with preservative|Influenza, split virus, trivalent, preservative|141       |Sanofi Pasteur|PMC       |Active|Active|2024/05/14|
